Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting α3 integrin
Published in European Journal of Nuclear Medicine and Molecular Imaging
PurposePatients with glioblastoma usually have a very poor prognosis. Even with a combination of radiotherapy plus temozolomide, the median survival of these patients is only 14.6 months. New treatment approaches to this cancer are needed. Our purpose is to develop new cell surface-binding ligands for glioblastoma cells and use them as targeted ima...
